Ardelyx (ARDX) Asset Utilization Ratio (2014 - 2026)
Ardelyx (ARDX) reported Asset Utilization Ratio of 0.64 for Q1 2026, down 25.44% on a YoY basis from 0.86 in Q1 2025, and up 4.83% quarter-over-quarter from 0.61 in Q4 2025.
Ardelyx (ARDX) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
Ardelyx has reported Asset Utilization Ratio for 11 years, with the latest figure at 0.64 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 25.44% year-over-year to 0.64; the trailing twelve-month figure through Mar 2026 stood at 0.64 (down 25.44% YoY), and the FY2025 full-year result was 0.87, down 4.48% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.64, up from 0.61 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.88 in Q2 2025, with the low at 0.03 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.49 across 5 years, with a median of 0.54 in 2023.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 54.61% — and 2023, when it jumped 986.31%.
- Ardelyx's Asset Utilization Ratio stood at 0.31 in 2022, then soared by 36.08% to 0.42 in 2023, then jumped by 95.79% to 0.83 in 2024, then fell by 26.75% to 0.61 in 2025, then gained by 4.83% to 0.64 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.64 (Q1 2026), 0.61 (Q4 2025), and 0.61 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 0.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.64 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | 0.61 |
| Jun 30, 2025 | 0.88 |
| Mar 31, 2025 | 0.86 |
| Dec 31, 2024 | 0.83 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | 0.61 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.42 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 0.39 |
| Mar 31, 2023 | 0.31 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.07 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.06 |